Parasellar Meningiomas.
Graillon T, Regis J, Barlier A, Brue T, Dufour H, Buchfelder M.
Neuroendocrinology. 2020;110(9-10):780-796. doi: 10.1159/000509090. Epub 2020 Jun 3.
Childhood-onset Craniopharyngioma.
Otte A, Müller HL.
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3820-e3836. doi: 10.1210/clinem/dgab397.
Radiotherapy of Parasellar Tumours.
Albano L, Losa M, Flickinger J, Mortini P, Minniti G.
Neuroendocrinology. 2020;110(9-10):848-858. doi: 10.1159/000506902. Epub 2020 Mar 4.
Diabetes insipidus secondary to sellar/parasellar lesions.
Angelousi A, Mytareli C, Xekouki P, Kassi E, Barkas K, Grossman A, Kaltsas G.
J Neuroendocrinol. 2021 Mar;33(3):e12954. doi: 10.1111/jne.12954.
Imaging of Sella and Parasellar Region.
Kirsch CFE.
Neuroimaging Clin N Am. 2021 Nov;31(4):541-552. doi: 10.1016/j.nic.2021.05.010.
Histopathology of Parasellar Neoplasms.
Manojlovic-Gacic E, Rostami E, Karavitaki N, Casar-Borota O.
Neuroendocrinology. 2020;110(9-10):740-752. doi: 10.1159/000507084. Epub 2020 Mar 11.
Craniopharyngioma.
Jane JA Jr, Laws ER.
Pituitary. 2006;9(4):323-6. doi: 10.1007/s11102-006-0413-8.
A clinical approach to parasellar lesions in the transition age.
Sbardella E, Puliani G, Feola T, Pofi R, Pirchio R, Sesti F, Verdecchia F, Gianfrilli D, Moffat D, Isidori AM, Grossman AB; Talent group.
J Neuroendocrinol. 2021 Jun;33(6):e12995. doi: 10.1111/jne.12995.
Craniopharyngiomas.
Karavitaki N, Cudlip S, Adams CB, Wass JA.
Endocr Rev. 2006 Jun;27(4):371-97. doi: 10.1210/er.2006-0002. Epub 2006 Mar 16.
Diagnosis and Treatment of Parasellar Lesions.
Gatto F, Perez-Rivas LG, Olarescu NC, Khandeva P, Chachlaki K, Trivellin G, Gahete MD, Cuny T; on behalf of the ENEA Young Researchers Committee (EYRC).
Neuroendocrinology. 2020;110(9-10):728-739. doi: 10.1159/000506905. Epub 2020 Mar 4.
